- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04655547
Impact on Energy Intake by Implementing Recommended Food Texture Through Dietary Guidance
Impact on Energy Intake by Implementing Recommended Food Texture Through Dietary Guidance at the Department of Swallowing and Eating Disorders; a Randomized Clinical Trial
An intervention study on the effect of dietary guidance with focus on implementing recommended food texture, at the department of Eating and Swallowing difficulties, Region Midtjylland, Denmark.
Energy- and protein intake, Weightloss, Bodymass composition, Fluid balance and Activities of Daily Living (ADL), will be measured by Bioimpedance spectroscopy, interviews and a questionnaire.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
It is know that people with eating- and swallowing difficulties(known as dysphagia), is prone to weightloss due to insufficient energy- and protein intake, and a reduction in ADL.
ADL will in this project have its focus on the eating situation.
The projects research questions are:
- Will dietary guidance with texture implementation increase energy intake in patients being examined on an outpatient basis for dysphagia, based on the Fiberoptic Endoscopic Evaluation of Swallowing (FEES) recommendation?
- Can a dietetic guidance with texture implementation increase quality of life and ADL in patients with dysphagia?
Recruitment and data collection will take place at Hammel Neurocenter, DK.
Each patient will be included for eight weeks, after their first FEES examination. The participants will be randomized to control or intervention, and strata into three groups based on Fiberoptic Endoscopic Dysphagia Severity Scale (FEDSS) 1, 2-3 and 4.
Within the eight weeks, participants have to show up three times to measurements, interviews and questionnaire, in addition to this, the intervention groups will have three follow-up phone meetings.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Midtjylland
-
Hammel, Midtjylland, Denmark, 8450
- Hammel neurorehabilitation centre and university research clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Signed consent form
- Newly refered patients to FEES examination
- Score 1-4 on FEDSS-scale
- Consumes 50% energy or more orally
- Consumes less energy than calculated energy need (Harris-Benedict)
- Individuals of full legal capacity
- Individuals above 18 of years
- That the patient is capable of executing examinations
Exclusion Criteria:
- Individuals with known eating disorders
- Ineligible individuals
- Individual in need of translator
- Individuals participating in another trial
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
The participants will follow the usual offered course on the outpatient clinic of Hammel Neurocenter.
They wil anticipate in data collection three times in line with the intervention group.
|
|
|
Experimental: Intervention
The participants will receive dietary guidance from an dietician, with focus on energy intake and food texture.
This guidance will include two sessions on site and three phone meetings.
The last on site meeting, will be concluding.
|
Dietary guidance with focus on texture and energy intake, preformed by certified dietitians.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in energy intake, from baseline.
Time Frame: Eight weeks
|
Change in energy intake, measured from baseline.
Measured in kilojoule by a standardized interview with examples of pictures to determine serving size.
|
Eight weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in Dysphagia Handicap Index (DHI) total and section (E and F) score.
Time Frame: Eight weeks
|
DHI is a questionnaire with 25 questions, divided into three sections. possible scores are minimum 25 and maximum 125. The higher the score, the worse dysphagia status. Measured in points, changes from baseline. |
Eight weeks
|
|
In how many questions in the DHI, does the intervention group change the score in relation to the control group, and with how much.
Time Frame: Eight weeks
|
Measured in points, changes from baseline.
|
Eight weeks
|
|
Body Weight.
Time Frame: Eight weeks
|
Measured in kilograms, by bioimpedance spectroscopy, changes from baseline.
|
Eight weeks
|
|
Lean Body Mass.
Time Frame: Eight weeks
|
Measured in kilograms, by bioimpedance spectroscopy, changes from baseline.
|
Eight weeks
|
|
Fat Mass.
Time Frame: Eight weeks
|
Measured in kilograms, by bioimpedance spectroscopy, changes from baseline.
|
Eight weeks
|
|
Fluid Balance.
Time Frame: Eight weeks
|
Measured in kilograms, by bioimpedance spectroscopy, changes from baseline.
|
Eight weeks
|
|
Changes in protein intake.
Time Frame: Eight weeks
|
Measured in gram, by a standardized interview with examples of pictures to determine serving size, from baseline.
|
Eight weeks
|
|
Compliance of recommended changes.
Time Frame: Eight weeks
|
Measured by score through interview.
Minimum score 1 and maximum score 5.
The greater the score, the better compliance.
|
Eight weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Jesper Fabricius, Ph.d., Hammel neurorehabilitation centre and university research clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- MS19953
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
Clinical Trials on Dietary guidance
-
Tianjin Medical University Cancer Institute and...CompletedEnteral Nutrition | Esophageal Squamous Cell Carcinoma | ChemoradiotherapyChina
-
West China HospitalNot yet recruiting
-
Cedars-Sinai Medical CenterNot yet recruitingCerebral Blood Flow | APOE 4United States
-
Sichuan UniversityNot yet recruiting
-
University of California, San DiegoAmerican Pistachio GrowersCompleted
-
Central Finland Hospital DistrictUnknown
-
Second Affiliated Hospital, School of Medicine,...Recruiting
-
Haukeland University HospitalGC Rieber Oils ASRecruitingRheumatoid Arthritis | Spondyloarthritis | PolyarthritisNorway
-
Sheba Medical CenterHebrew University of JerusalemCompletedType 2 Diabetes | Aging | Cognitive DeclineIsrael
-
Emergency Medical Service of the Central Bohemian...Masaryk Hospital Usti nad LabemCompleted